BRIEF-APPLIED BIOMATH SAYS TO COLLABORATE WITH CYTOMX THERAPEUTICS

* SAYS TO COLLABORATE WITH CYTOMX THERAPEUTICS TO DEVELOP QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL OF CYTOMX THERAPEUTICS' PROBODY PLATFORM Source text for Eikon: Further company coverage: [Source]

Publication Date: Tuesday, 31 January 2017 at 22:06:52

Origin: reuters.com

Category: rbssHealthcareNews

Topics: CYTOMX, THERAPEUTICS, COLLABORATE, coverage, company, Further, Eikon, PLATFORM Source, THERAPEUTICS' PROBODY, MODEL, PHARMACOLOGY, SYSTEMS, DEVELOP QUANTITATIVE, BIOMATH, BRIEF-APPLIED

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/Uc3k8dH2Lpg/idUSFWN1FL0XJ

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22

Analyzed News